You are using an outdated browser. Please upgrade your browser to improve your experience.

trilaciclib

Ligand Summary
Ligand Structure
Rendered image for the query structure
Description
Trilaciclib is a transient inhibitor of CDK 4 and 6. Hematopoietic stem and progenitor cells (HSPCs) in the bone marrow give rise to circulating neutrophils, RBCs, and platelets. HSPC proliferation is dependent on CDK4/6 activity.
Synonyms & Links
Guide to Pharmacology: 9626
DrugCentral: 5442
LyCHI:  XDU2WJ5CMMNN


Target Activities